Estrozora 2.5 Tablets
Estrozora 2.5 (Letrozole) is indicated for the treatment of hormone receptor-positive early breast cancer in postmenopausal women. It is also used for extended adjuvant treatment and first-line treatment of advanced breast cancer in postmenopausal women.
As directed by the Cancer Specialist/Gynecologist.
Store in a cool, dry & dark place at a temperature not exceeding 30°C. protected from direct sunlight.
Letrozole is a non-steroidal aromatase inhibitor. It works by blocking the enzyme aromatase, which converts androgens into estrogens. This significantly reduces estrogen levels in the body, thereby inhibiting the growth of estrogen-dependent breast cancer cells.
- Treats hormone-sensitive breast cancer in postmenopausal women.
- Reduces estrogen levels to inhibit cancer cell growth.
- Effective in various stages of breast cancer treatment, including adjuvant and advanced cases.
* % Daily Value based on 2000 kcal diet. As directed by physician.
Each film coated tablet contains: Letrozole IP 2.5 mg, Excipients q.s., Colour : Approved colour used in tablets
